Key facts
- Uman Sense’s last known valuation is $46.3M (Dec 2024).
- It has raised $9.2M; the latest was Later Stage VC ($6.3M) in Dec 2024.
- Notable investors include Almi Invest, Nordic Mentor Network For Entrepreneurship, EIT Health, Fårö Capital, GOBIA Enterprises — 15 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 15 names
- ·Watchlist + deal alerts for Uman Sense
- ·The full record, as it builds
Funding rounds
No funding rounds for Uman Sense are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Uman Sense
Developer of a wearable stroke detection device designed to enable timely intervention for suspected stroke patients. The company's platform continuously monitors users' arm movements, analyzes movement patterns to identify potential stroke symptoms, and automatically notifies pre-selected contacts when suspicion is detected, enabling healthcare providers and caregivers in the stroke care market to accelerate treatment decisions and improve patient outcomes.
- Sector
- Healthcare
- HQ
- Lund, Sweden
- Founded
- 2014
- Employees
- 9
- Website
- umansense.com/
- Ownership
- Privately Held (backing)
Uman Sense doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Uman Sense shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Uman Sense in its N-PORT filings yet. We sweep new filings monthly.